Covishield: 2nd – 3rd Phase trails

Covishield: 2^nd – 3^rd Phase trails

Recently, the Drugs Controller General of India (DCGI) has given approval to the Serum Institute of India (SII), Pune to conduct Phase II/III clinical trials of Covishield in India. SII is the world’s largest maker of vaccines and it has a tie-up with AstraZeneca, the Swedish-British pharma giant, to manufacture the Covid-19 vaccine for low- and middle-income countries.

Covishield:
It is the name given to an Oxford-AstraZeneca Covid-19 vaccine candidate which is technically referred to as AZD1222 or ChAdOx 1 nCoV-19.
It is already being tested in the UK, South Africa and Brazil, where participants are being administered two doses nearly a month apart.
It had triggered an immune response in humans against the novel coronavirus in early trials and is considered to be one of the global frontrunners for the Covid-19 vaccine.

Background: The Subject Expert Committee (SEC) for Covid-19-related therapies of the Central Drugs Standard Control Organisation (CDSCO) felt that the SII needed to take a ‘pan India’ approach while considering trial sites.

It recommended that authorisation to market Covishield should be granted after considering clinical data generated from both the India and international trials.
Trials: SII can now start its larger phase II/III trials, ahead of other vaccine candidates like Bharat Biotech’s Covaxin and Zydus Cadila’s ZyCov-D which are still in phase I/II trials.
However, the exact timings of the trial beginning are not clear yet. It would take at least a week to get the ethics committee’s approval before starting the trials. If everything goes well, the vaccine could be out by the end of 2020.
The trials for Covishield will have around 1,600 participants at 18-odd sites across the country including those identified by the National Biopharma Mission and Grand Challenges India Programme.

Current Trend in India: India continues to improve the Case Fatality Rate (CFR-number of deaths per positive case) and maintain its global position of having one of the lowest Covid-19 fatalities rates. The current CFR is 2.11%.

Grand Challenges India Programm

It is a partnership framework for the Department of Biotechnology (DBT) in India, its Biotechnology Industry Research Assistance Council (BIRAC) and the Bill and Melinda Gates Foundation. BIRAC is a Public Sector Enterprise, set up by the DBT.
Aim: To launch joint initiatives aimed at catalyzing innovative health and development research within India.

National Biopharma Mission

It is an industry-academia collaborative mission for accelerating biopharmaceutical development in the country.
It was launched in 2017 at a total cost of Rs. 1500 crore and is 50% co-funded by a World Bank loan.
It is being implemented by the BIRAC.

Source: TH

Join Our Telegram

US Resumes Nuclear Weapon Testing

Formation Day

03 Dec, 25
SHARE

On 1st November, eight Indian states—Andhra Pradesh, Chhattisgarh, Haryana, Karnataka, Kerala, Madhya Pradesh, Punjab, and Tamil Nadu—along with five Union Territories—Andaman and Nicobar Islands, Chandigarh, Delhi, Lakshadweep, and Puducherry—celebrate their Formation Day. This date marks an important milestone in India

Turtle (Kachhua) Wildlife Sanctuary

02 Dec, 25
SHARE

The Turtle Wildlife Sanctuary, also known as the Kachhua Sanctuary, is located in the Varanasi district of Uttar Pradesh. It is recognised as India’s first freshwater turtle wildlife sanctuary, established to conserve endangered turtle species and support the ecological health of the Ganga River. Location and Extent The sanctuary co

Introduction of AI and Computational Thinking (CT) in

02 Dec, 25
SHARE

The Ministry of Education plans to introduce Artificial Intelligence (AI) and Computational Thinking (CT) from Class 3 onwards in the 2026–27 academic year. This initiative is part of the National Curriculum Framework for School Education (NCF-SE) 2023 and aligns with the National Education Policy (NEP) 2020. The aim is to prepare student

Sal Tree

02 Dec, 25
SHARE

Scientists from the Environment Department of Himachal Pradesh University (HPU) in Shimla have recently revealed that the Sal tree (Shorea robusta) is the most effective natural air purifier for combating rising pollution levels. Their findings highlight the tree’s superior capacity to trap dust, absorb gases, and cleanse the air compared

US Resumes Nuclear Weapon Testing

02 Dec, 25
SHARE

The President of the United States has ordered the resumption of nuclear weapon testing after a gap of 33 years, the last test being in 1992. This decision marks a significant shift in global nuclear policy and has far-reaching implications for geopolitics, the environment, and international security. Status of Global Nuclear Weapon Testing